LEADER 00977nam  2200361   450 
001 9910265149703321
005 20221012135803.0
010   $a953-51-3975-4
010   $a953-51-3826-X
035   $a(CKB)4100000002890934
035   $a(NjHacI)994100000002890934
035   $a(EXLCZ)994100000002890934
100   $a20221012d2018      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAntibody engineering /$fedited by Thomas Bo?ldicke
210  1$aRijeka, Croatia :$cIntechOpen,$d[2018]
210  4$dİ2018
215   $a1 online resource (312 pages)
311   $a953-51-3825-1 
606   $aImmunoglobulins
615  0$aImmunoglobulins.
676   $a616.0798
702   $aBo?ldicke$b Thomas
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910265149703321
996   $aAntibody Engineering$91937003
997   $aUNINA